CN102552767A - Traditional Chinese medicine for treating kidney stone, preparation method and administration mode - Google Patents
Traditional Chinese medicine for treating kidney stone, preparation method and administration mode Download PDFInfo
- Publication number
- CN102552767A CN102552767A CN2012100624932A CN201210062493A CN102552767A CN 102552767 A CN102552767 A CN 102552767A CN 2012100624932 A CN2012100624932 A CN 2012100624932A CN 201210062493 A CN201210062493 A CN 201210062493A CN 102552767 A CN102552767 A CN 102552767A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- obtains
- chinese medicine
- quality
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 87
- 208000000913 Kidney Calculi Diseases 0.000 title claims abstract description 36
- 206010029148 Nephrolithiasis Diseases 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 42
- 241000628997 Flos Species 0.000 claims abstract description 39
- 241000959626 Calvatia Species 0.000 claims abstract description 19
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 221
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 106
- 238000010828 elution Methods 0.000 claims description 48
- 239000000203 mixture Substances 0.000 claims description 43
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 39
- 239000003480 eluent Substances 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 27
- 238000009835 boiling Methods 0.000 claims description 26
- 238000001914 filtration Methods 0.000 claims description 23
- 238000002347 injection Methods 0.000 claims description 23
- 239000007924 injection Substances 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 20
- 241001057584 Myrrha Species 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 19
- 239000012141 concentrate Substances 0.000 claims description 19
- 241000545442 Radix Species 0.000 claims description 18
- 230000001476 alcoholic effect Effects 0.000 claims description 18
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 18
- 239000011347 resin Substances 0.000 claims description 16
- 229920005989 resin Polymers 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 239000002552 dosage form Substances 0.000 claims description 13
- 210000002784 stomach Anatomy 0.000 claims description 12
- 230000008961 swelling Effects 0.000 claims description 11
- 239000003463 adsorbent Substances 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 241001072382 Glechoma Species 0.000 claims description 9
- 241000245240 Lonicera Species 0.000 claims description 9
- 241000612166 Lysimachia Species 0.000 claims description 9
- 241001446509 Psoralea Species 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000000314 lubricant Substances 0.000 claims description 9
- 229920006122 polyamide resin Polymers 0.000 claims description 9
- 238000011084 recovery Methods 0.000 claims description 9
- 238000009495 sugar coating Methods 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 7
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 238000001179 sorption measurement Methods 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 5
- JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- 239000004411 aluminium Substances 0.000 claims description 4
- 229920005549 butyl rubber Polymers 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 241001597008 Nomeidae Species 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000009501 film coating Methods 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229960003943 hypromellose Drugs 0.000 claims description 3
- 238000005461 lubrication Methods 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 241001421953 Eclipta <beetle> Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 40
- 239000004575 stone Substances 0.000 abstract description 14
- 230000003907 kidney function Effects 0.000 abstract description 5
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 238000009212 extracorporeal shock wave lithotripsy Methods 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 49
- 210000004369 blood Anatomy 0.000 description 46
- 239000008280 blood Substances 0.000 description 46
- 208000002193 Pain Diseases 0.000 description 29
- 230000036407 pain Effects 0.000 description 29
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 24
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 22
- 239000013078 crystal Substances 0.000 description 20
- 230000001737 promoting effect Effects 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 19
- 210000002700 urine Anatomy 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 18
- 238000000034 method Methods 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 238000010792 warming Methods 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 11
- 210000003932 urinary bladder Anatomy 0.000 description 10
- 208000032843 Hemorrhage Diseases 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 210000001624 hip Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 235000021251 pulses Nutrition 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 238000002504 lithotomy Methods 0.000 description 7
- 235000006408 oxalic acid Nutrition 0.000 description 7
- 230000001047 pyretic effect Effects 0.000 description 7
- 244000286838 Eclipta prostrata Species 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 208000002881 Colic Diseases 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 208000009911 Urinary Calculi Diseases 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 208000006750 hematuria Diseases 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 231100000111 LD50 Toxicity 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 238000002309 gasification Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 239000001508 potassium citrate Substances 0.000 description 3
- 229960002635 potassium citrate Drugs 0.000 description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 3
- 235000011082 potassium citrates Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000000626 ureter Anatomy 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000031868 Calculus ureteric Diseases 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000000014 Ureteral Calculi Diseases 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HLVXFWDLRHCZEI-UHFFFAOYSA-N chromotropic acid Chemical compound OS(=O)(=O)C1=CC(O)=C2C(O)=CC(S(O)(=O)=O)=CC2=C1 HLVXFWDLRHCZEI-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 210000000244 kidney pelvis Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 241001073507 Callicarpa Species 0.000 description 1
- 241001136615 Callicarpa dichotoma Species 0.000 description 1
- 241001497937 Callicarpa pedunculata Species 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000023329 Gun shot wound Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000008718 Pyuria Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010038419 Renal colic Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- MXZRMHIULZDAKC-UHFFFAOYSA-L ammonium magnesium phosphate Chemical compound [NH4+].[Mg+2].[O-]P([O-])([O-])=O MXZRMHIULZDAKC-UHFFFAOYSA-L 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- XIKIPZDTTJQYGT-UHFFFAOYSA-L calcium;6,8-dioxo-7,9-dihydro-3h-purin-2-olate Chemical compound [Ca+2].N1C([O-])=NC(=O)C2=C1NC(=O)N2.N1C([O-])=NC(=O)C2=C1NC(=O)N2 XIKIPZDTTJQYGT-UHFFFAOYSA-L 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 235000015861 monopotassium citrate Nutrition 0.000 description 1
- 239000002444 monopotassium citrate Substances 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000008807 pathological lesion Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- WKZJASQVARUVAW-UHFFFAOYSA-M potassium;hydron;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].OC(=O)CC(O)(C(O)=O)CC([O-])=O WKZJASQVARUVAW-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000036228 toxication Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Dosage (g) | Chinese medicine of the present invention | Monopotassium citrate |
Adult 60kg | 30.0 | 25.0 |
SD rat 200g * coefficient (k=6.25) | 0.6 | 0.5 |
Group | n | The kidney calcium oxalate crystal (/HP) | Right kidney oxalic acid content (mmol/L) |
The A group | 30 | 43.1±30.7 | 0.81±0.25 |
The B group | 30 | 10.0±9.6 | 0.41±0.12 |
The C group | 30 | 12.8±10.7 | 0.75±0.23 |
Group | n | Cure | Effectively | Invalid | Total effective rate |
The treatment group | 60 | 45 | 12 | 3 | 95% |
Matched group | 20 | 24 | 6 | 10 | 75% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210062493 CN102552767B (en) | 2012-03-12 | 2012-03-12 | Traditional Chinese medicine for treating kidney stone, preparation method and administration mode |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210062493 CN102552767B (en) | 2012-03-12 | 2012-03-12 | Traditional Chinese medicine for treating kidney stone, preparation method and administration mode |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552767A true CN102552767A (en) | 2012-07-11 |
CN102552767B CN102552767B (en) | 2013-07-10 |
Family
ID=46400221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210062493 Expired - Fee Related CN102552767B (en) | 2012-03-12 | 2012-03-12 | Traditional Chinese medicine for treating kidney stone, preparation method and administration mode |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552767B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103251684A (en) * | 2013-06-09 | 2013-08-21 | 李伟丽 | Medicine composition for treating kidney stone and preparation method of drug composition |
CN103272082A (en) * | 2013-05-01 | 2013-09-04 | 韩明镜 | Preparation method of traditional Chinese medicine decoction for treating pulmonary hypertension |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1228321A (en) * | 1998-12-23 | 1999-09-15 | 王有星 | Drug for curing stone of urinary system |
CN101653582A (en) * | 2009-09-16 | 2010-02-24 | 刘艳菊 | Medicine for curing nephrolithiasis |
-
2012
- 2012-03-12 CN CN 201210062493 patent/CN102552767B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1228321A (en) * | 1998-12-23 | 1999-09-15 | 王有星 | Drug for curing stone of urinary system |
CN101653582A (en) * | 2009-09-16 | 2010-02-24 | 刘艳菊 | Medicine for curing nephrolithiasis |
Non-Patent Citations (2)
Title |
---|
刘宜铭等: "《补肾通石汤治疗泌尿系结石30例》", 《江苏中医》 * |
刘杰: "《贺瑞麟治疗上尿路结石的经验》", 《辽宁中医杂志》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103272082A (en) * | 2013-05-01 | 2013-09-04 | 韩明镜 | Preparation method of traditional Chinese medicine decoction for treating pulmonary hypertension |
CN103251684A (en) * | 2013-06-09 | 2013-08-21 | 李伟丽 | Medicine composition for treating kidney stone and preparation method of drug composition |
CN103251684B (en) * | 2013-06-09 | 2014-09-03 | 李伟丽 | Medicine composition for treating kidney stone and preparation method of drug composition |
Also Published As
Publication number | Publication date |
---|---|
CN102552767B (en) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101884770B (en) | Chinese medicinal preparation for treating urolithiasis and preparation method thereof | |
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN102178804B (en) | Chinese medicinal composition for treating perianal eczema and preparation method thereof | |
CN102178800B (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
CN104352991A (en) | Traditional Chinese medicine preparation for treating gout and preparation method thereof | |
CN103520694B (en) | Traditional Chinese medicine composition capable of treating chronic obstructive pulmonary disease in stabilization period and preparation method of composition | |
CN103705687B (en) | A kind ofly prevent and treat Chinese medicine composition of early stage chronic kidney hypofunction and preparation method thereof | |
CN104815192A (en) | Pharmaceutical composition for treating hypertension and application of pharmaceutical composition | |
CN104587302A (en) | Traditional Chinese medicine preparation for treating acute appendicitis | |
CN104042971A (en) | Medicine composition for treating yin deficiency toxic heat lung cancer and preparation method thereof | |
CN102552767B (en) | Traditional Chinese medicine for treating kidney stone, preparation method and administration mode | |
CN104645232A (en) | Traditional Chinese medicine combinatorial composition for treatment of double-flexure syndrome and preparation method and applications thereof | |
CN104784549A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
CN102430008B (en) | Chinese medicinal composition for treating gastrointestinal disease and preparation method thereof | |
CN103191399A (en) | Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period | |
CN103386101B (en) | Traditional Chinese medicine preparation for nonspecific cystitis treatment and preparation method thereof | |
CN105147956A (en) | Traditional Chinese medicine for treating acute peptic ulcer bleeding and preparation method of traditional Chinese medicine | |
CN105079721A (en) | Traditional Chinese medicine composition for treating osteoarthritis and preparing method thereof | |
CN104666475A (en) | Coptis chinensis and donkey-hide gelatin composition for treating sicca syndrome and application of coptis chinensis and donkey-hide gelatin composition | |
CN110478416A (en) | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis | |
CN104225498A (en) | Drug composition for treating primary cold-damp congealing dysmenorrheal and preparation method thereof | |
CN108578607A (en) | A kind of pharmaceutical composition for treating kidney stone | |
CN103479915B (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
CN103386104B (en) | Traditional Chinese medicine composite for curing erysipelas and preparation method thereof | |
CN102940674B (en) | Medicine composition for treating benign prostatic hyperplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SUN XIA Free format text: FORMER OWNER: LIU XIA Effective date: 20130701 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Bian Luyan Inventor after: Sun Xia Inventor after: Liu Xia Inventor before: Liu Xia |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU XIA TO: BIAN LUYAN SUN XIA LIU XIA Free format text: CORRECT: ADDRESS; FROM: 237222 LU'AN, ANHUI PROVINCE TO: 266071 QINGDAO, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130701 Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 Minmetals building room 801 Patentee after: Sun Xia Address before: 237222 Anhui Province, Mount Holyoke county but the streets but Jia Miao Zhen Jia Miao Cun Patentee before: Liu Xia |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 237222 Anhui city in Lu'an Province, but the streets of Mount Holyoke County Shilin equipment company Jia Miao Zhen Hospital Patentee after: Sun Xia Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 Minmetals building room 801 Patentee before: Sun Xia |
|
ASS | Succession or assignment of patent right |
Owner name: HUANG YARONG Free format text: FORMER OWNER: SUN XIA Effective date: 20141231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 237222 LU'AN, ANHUI PROVINCE TO: 213000 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: 213000 Jiangsu city of Changzhou province Xinbei District Xiang Long Yuan building 1203 room 18 Patentee after: Huang Yarong Address before: 237222 Anhui city in Lu'an Province, but the streets of Mount Holyoke County Shilin equipment company Jia Miao Zhen Hospital Patentee before: Sun Xia |
|
ASS | Succession or assignment of patent right |
Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., Free format text: FORMER OWNER: HUANG YARONG Effective date: 20150504 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 213000 CHANGZHOU, JIANGSU PROVINCE TO: 226534 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150504 Address after: 226534 Jiangsu city of Nantong province Rugao City Jiangan town Fu Road No. 166 Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD. Address before: 213000 Jiangsu city of Changzhou province Xinbei District Xiang Long Yuan building 1203 room 18 Patentee before: Huang Yarong |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130710 Termination date: 20190312 |
|
CF01 | Termination of patent right due to non-payment of annual fee |